Skip to main content

Rafael Holdings, Inc.

RFL
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001713863

No open-market purchases or sales by Rafael Holdings, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $12.7M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding Rafael Holdings, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of RFL: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders45450
Shares2.56M2.76M+201.0K (+7.9%)
Value$3.96M$5.71M+$1.75M (+44.1%)

New holders (5)

Institutions that held Rafael Holdings, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to RFL in Q2 2023
InstitutionSharesValue% of portfolio
Acuitas Investments, LLC233,424$487.9K0.28%
Rhumbline Advisers3,304$6.91K0.00%
Royal Bank of Canada2,576$5.00K0.00%
Covestor Ltd5$00.00%
Meitav Dash Investments Ltd27,000––

Sold out (5)

Institutions that held Rafael Holdings, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of RFL in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
HRT Financial LP22,443$34.0K
Charles Schwab Investment Management Inc16,601$25.7K
Cubist Systematic Strategies, LLC10,284$15.9K
Point72 Asset Management, L.P.409$634
Northwestern Mutual Wealth Management Co160$248